Kymera Therapeutics, Inc. (KYMR)
75.29
+1.16
(+1.56%)
USD |
NASDAQ |
Jan 14, 16:00
75.29
0.00 (0.00%)
After-Hours: 18:59
Kymera Therapeutics Price: 75.29 for Jan. 14, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Regeneron Pharmaceuticals, Inc. | 754.08 |
| Gilead Sciences, Inc. | 124.07 |
| Cytokinetics, Inc. | 64.57 |
| TG Therapeutics, Inc. | 29.56 |
| Protagonist Therapeutics, Inc. | 85.19 |
Price Related Metrics
| PS Ratio | 141.12 |
| PEG Ratio | -0.3843 |
| Price to Book Value | 5.725 |
| Earnings Yield | -4.78% |
| Market Cap | 5.417B |
| PEGY Ratio | -0.3843 |